Crispr Therapeutics Ag (0VRQ)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -13.437 | -22.183 | -43.395 | 8.595 | -24.104 | 16.492 | -26.033 | -6.869 |
| Return on Equity (%) | -19.908 | -32.498 | -56.887 | 10.042 | -26.798 | 18.587 | -30.418 | -8.174 |
| Return on Invested Capital (%) | -13.204 | -33.057 | -57.642 | 10.117 | -27.05 | 18.773 | -31.084 | -8.364 |
| Operating Margin (%) | -284.043 | -162.47 | -5263.38 | 23.242 | -48408.345 | 41.48 | -54298.831 | -40.603 |
| Net Profit Margin (%) | -448.819 | -166.737 | -5281.082 | 23.087 | -48520.862 | 41.276 | -54271.703 | -41.381 |
| Book Value Per Share | 5.852 | 4.619 | 7.558 | 15.451 | 22.513 | 31.237 | 23.942 | 23.572 |
| Earnings Per Share | -0.584 | -1.684 | -3.182 | 1.1 | -4.72 | 4.917 | -8.3 | -1.923 |
| Cash Per Share | 7.944 | 5.907 | 8.807 | 15.527 | 15.81 | 12.017 | 2.705 | 4.876 |
| Working Capital Per Share | 7.507 | 5.762 | 8.459 | 15.307 | 21.949 | 29.913 | 22.11 | 22.527 |
| Operating Profit Per Share | 2.396 | 1.01 | 0.06 | 5.193 | 0.096 | 11.99 | 0.305 | 5.547 |
| EBIT Per Share | -0.572 | -1.641 | -3.171 | 1.107 | -4.709 | 4.941 | -8.304 | -1.887 |
| EBITDA Per Share | -0.572 | -1.641 | -3.171 | 1.107 | -4.709 | 4.941 | -8.304 | -1.887 |
| Free Cash Flow Per Share | -0.531 | -1.566 | -3.196 | 1.132 | -4.596 | 5.747 | -8.134 | -2.053 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 39.72M | 40.59M | 51.85M | 60.78M | 73.92M | 76.81M | 78.33M | 79.87M |
| Market Cap | 5.16B |
| Price to Earnings Ratio | -33.59 |
| Price to Sales Ratio | 13.9 |
| Price to Cash Ratio | 13.25 |
| Price to Book Ratio | 2.74 |
| Dividend Yield | - |
| Shares Outstanding | 79.87M |
| Average Volume (1 week) | 5.07k |
| Average Volume (1 Month) | 5.91k |
| 52 Week Change | 0.00% |
| 52 Week High | 64.60 |
| 52 Week Low | 64.60 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
